News & Media
Progress today for a brighter tomorrow.
Company announcements, press releases, and updates from the LurexBio team as we advance recognition engineering for immune-cold cancers.
Company news and press releases.
Announcements and articles published by LurexBio.
17
Oct
Why start with immune recognition?
Many solid tumors evade immune recognition. Here is why LurexBio starts upstream, at the recognition step other immunotherapies depend on.
06
Nov
Lurex Bio Announces Patent Filings and a New Frontier in Immune Engineering
Lurex Bio has filed multiple U.S. provisional patent applications covering its immune-signal and vesicle-based targeting systems, its first step toward international protection under the Patent Cooperation Treaty.
Latest from LurexBio
Updates from our LinkedIn page, refreshed automatically.
Posts open on LinkedIn.